Anemia Industry, August 2014 Market Reports from Top Publishers

You might be interested in: nucleic acid testing, chemotherapy, therapeutics, more »


 
1-10 of 38 reports for Anemia

Anemia Partnering 2009-2014

Anemia Partnering 2009-2014

  • $ 695
  • Industry report
  • August 2014
  • by Currentpartnering

... To online copies of actual anemia deals and contract documents as submitted to the securities exchange commission by companies and their partners, where available. Contract documents provide the answers ...

 Aplastic Anemia-Pipeline Insights, 2014

Aplastic Anemia-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... This indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under aplastic anemia. This report provides information on the therapeutic development based ...

 Chemotherapy Induced Anemia-Pipeline Insights, 2014

Chemotherapy Induced Anemia-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... Drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under chemotherapy induced anemia. This report provides information ...

 Iron Deficiency Anemia-Pipeline Insights, 2014

Iron Deficiency Anemia-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... This indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under iron deficiency anemia. This report provides information on the therapeutic development ...

 Renal Anemia-Pipeline Insights, 2014

Renal Anemia-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... A key objective of the report is to establish the understanding for all the pipeline drugs that fall under renal anemia. This report provides information on the therapeutic development based ...

 Congenital Hypoplastic Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Congenital Hypoplastic Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Reasons to buy - evaluate the marketing status and exclusivity details of congenital hypoplastic anemia key products to exploit opportunities for generic drug development opportunities. - Identify ...

 Pernicious Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Pernicious Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Of pernicious anemia key products to exploit opportunities for generic drug development opportunities. - Identify and understand important and diverse types of therapeutics under phase iii development ...

 Renal Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Renal Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... To exploit opportunities for generic drug development opportunities. - Identify and understand important and diverse types of therapeutics under phase iii development for renal anemia. - Design ...

 Megaloblastic Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Megaloblastic Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Evaluate the marketing status and exclusivity details of megaloblastic anemia key products to exploit opportunities for generic drug development opportunities. - Identify and understand important ...

 Aplastic Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Aplastic Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Of aplastic anemia key products to exploit opportunities for generic drug development opportunities. - Identify and understand important and diverse types of therapeutics under phase iii development ...

About 2 400 reports for Anemia

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Pakistan

  • Prevalence of Anemia in Pregnant Women in District Karak,
  • November 2013
    7 pages
  • Anemia  

  • Pakistan  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.